Related Experiment Videos
Acceptance and versatility of the Ross procedure
Current Opinion in Cardiology
|April 7, 1999
Summary
The Ross procedure, using a patient's own pulmonary valve (autograft), shows excellent long-term results in various patient groups. It offers good growth in children and low thromboembolism risk without anticoagulation.
Area of Science:
- Cardiovascular Surgery
- Thoracic Surgery
- Pediatric Cardiology
Background:
- The Ross procedure utilizes a pulmonary autograft for aortic valve replacement.
- Long-term data collection over 31 years provides insights into autograft performance.
Purpose of the Study:
- To assess the long-term efficacy and safety of the pulmonary autograft in the Ross procedure.
- To evaluate the suitability of the Ross procedure across diverse patient demographics and conditions.
Main Methods:
- Analysis of 31 years of collected data on patients undergoing the Ross procedure.
- Review of outcomes related to autograft growth, thromboembolism, endocarditis, and valve function under stress.
- Evaluation of the impact of surgical technique modifications (e.g., root replacement, annular narrowing) on early regurgitation.
Main Results:
- The pulmonary autograft demonstrates excellent long-term performance, supporting its use in young patients, women of childbearing age, and those with congenital aortic stenosis or complex outflow tract obstruction.
- Low rates of thromboembolism observed without anticoagulation.
- Significant autograft growth in children.
- Good outcomes in endocarditis treatment.
- Autograft function comparable to a normal aortic valve under high stress.
- Improved outcomes regarding early regurgitation with modified implantation techniques.
Conclusions:
- The Ross procedure with a pulmonary autograft is highly effective and reproducible.
- It is a suitable option for a wide range of patients, including children and those with specific cardiac conditions.
- While a potential for immune response exists, overall results are excellent.